Advancing Pediatric Cancer Treatment with Transcription Factor Targeting

John Bushweller, PhD, Professor of Molecular Physiology and Biological Physics at UVA and co-leader of the Cancer Biology Program at UVA Comprehensive Cancer Center, is collaborating with C-Further, an international consortium dedicated to advancing new therapies for childhood cancers, to develop a new treatment option that targets a transcription factor that fuels Ewing Sarcoma. The goal is a new drug that could offer better outcomes with less toxicity.

Read more: https://www.uvahealth.com/healthy-practice/advancing-pediatric-cancer-treatment-with-transcription-factor-targeting